Candesartan Cilexetil Drug Market Report 2026

Candesartan Cilexetil Drug Market Overview

• Candesartan Cilexetil Drug market size has reached to $1.65 billion in 2025 • Expected to grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Surge In Hypertension Prevalence Fueling The Growth Of The Market Due To Increased Lifestyle Risks And Demand For Effective Management Solutions • Market Trend: Advancements In Hypertension Treatment And The Shift Towards Patient-Friendly Drug Delivery Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Candesartan Cilexetil Drug Market?

Candesartan cilexetil drug refers to an angiotensin II receptor antagonist used primarily to treat high blood pressure and heart failure. It works by blocking the effects of angiotensin II, helping to relax blood vessels and reduce blood pressure. The main product types of candesartan cilexetil drug include tablets, capsules, and others. Tablets refer to solid dosage forms of medication, typically consisting of a mixture of active pharmaceutical ingredients and excipients, compressed into a small, convenient shape. The multiple indications involved are hypertension, heart failure, diabetic nephropathy, and left ventricular hypertrophy, with the dosage strengths of 4 mg, 8 mg, 16 mg, and 32 mg. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, and healthcare facilities, and are used for several applications, such as adults, children, and adolescents.

What Is The Candesartan Cilexetil Drug Market Growth Forecast?

The candesartan cilexetil drug market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growth in chronic cardiovascular diseases, expanding generic drug penetration, increasing combination drug adoption, improved access in developing regions, rising preventive cardiovascular care. Major trends in the forecast period include rising use of angiotensin receptor blockers in hypertension, increasing prescription for heart failure management, growing demand for generic antihypertensive drugs, expansion of combination therapy formulations, improved patient compliance through once-daily dosing.

Global Candesartan Cilexetil Drug Market Segmentation

1) By Product Type: Tablets, Capsules, Other Product Types 2) By Indication: Hypertension, Heart Failure, Diabetic Nephropathy, Left Ventricular Hypertrophy 3) By Dosage Strength: 4 MG, 8 MG, 16 MG, 32 MG 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Healthcare Facilities 5) By Application: Adult, Children And Adolescent Subsegments: 1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Dispersible Tablets, Chewable Tablets 2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules 3) By Other Product Types: Oral Suspensions, Injectable Formulations, Combination Drug Formulations

What Are The Drivers Of The Candesartan Cilexetil Drug Market?

The rising prevalence of hypertension is expected to propel the growth of the candesartan cilexetil drug market going forward. Hypertension, also known as high blood pressure, refers to a medical condition where the force of the blood against the walls of the arteries is consistently too high, typically defined as a reading of 130/80 mmHg or higher. The prevalence of hypertension is due to increasingly unhealthy lifestyle factors, such as poor diet, lack of physical activity, and high-stress levels. Candesartan cilexetil drug helps manage hypertension by blocking the action of angiotensin II, a hormone that constricts blood vessels, relaxing the blood vessels and reducing blood pressure. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, from August 2021 to August 2023, hypertension prevalence grew significantly, rising by 124.48% in the transition from the 18–39 age group to the 40–59 age group, and by 36.38% as it moved from the 40–59 age group to individuals aged 60 and older. Therefore, the increasing burden of hypertension is fueling demand for the candesartan cilexetil drug industry. The growing number of cardiovascular disorders is expected to propel the growth of the candesartan cilexetil drug market going forward. Cardiovascular disorders are health problems that affect the heart or blood vessels, making it harder for the heart to work properly. The rise in cardiovascular disorders is due to a lack of physical activity, which can contribute to obesity, high blood pressure, and poor cardiovascular health by reducing the efficiency of the heart and circulation. Candesartan cilexetil helps manage cardiovascular disorders by lowering blood pressure and reducing the strain on the heart, decreasing the risk of complications such as heart failure, stroke, and kidney damage. For instance, in January 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, around 7.6 million people in the UK lived with heart and circulatory diseases, approximately 4 million men and 3.6 million women. These conditions contribute to nearly 27% of all deaths in the country, resulting in over 170,000 fatalities each year, or roughly 480 deaths every day. Therefore, the growing cardiovascular disorders are driving the growth of the candesartan cilexetil drug industry.

Key Players In The Global Candesartan Cilexetil Drug Market

Major companies operating in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.

Global Candesartan Cilexetil Drug Market Trends and Insights

Major companies operating in the candesartan cilexetil drug market are focusing on developing innovative formulations such as treatments for hypertension, combination therapies with other antihypertensive drugs, and extended-release versions to improve patient adherence and enhance therapeutic outcomes. Treatment for hypertension is the use of medications, lifestyle changes, and other interventions aimed at lowering and managing high blood pressure (hypertension) to reduce the risk of complications such as heart disease, stroke, and kidney damage. For instance, in March 2025, Scienture Inc., a US-based pharmaceutical company, received approval from the US Food & Drug Administration (USFDA) for its New Drug Application (NDA) for SCN-102, launched as Arbli, a losartan potassium oral suspension (10 mg/mL). An angiotensin II receptor blocker (ARB) formulation offers an alternative for patients with difficulty swallowing tablets, particularly in pediatric and geriatric populations. The launch reflects the growing interest in alternative dosage forms in the antihypertensive market and underlines the shift toward personalized, patient-friendly drug delivery systems.

Regional Insights

North America was the largest region in the candesartan cilexetil drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Candesartan Cilexetil Drug Market?

The candesartan cilexetil drug market consists of sales of atacand, candesartan tablets, and oral tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Candesartan Cilexetil Drug Market Report 2026?

The candesartan cilexetil drug market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the candesartan cilexetil drug industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.